Has Ralph Augostini, MD received payments from drug or device companies?

Yes. Drug and device makers reported $174,345 in general payments to Ralph Augostini, MD across 213 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ralph Augostini, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ralph Augostini, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ralph Augostini, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1104821552

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $126,050 of the $174,345 with a category attached, or 72.3%. 10 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 41.6% of the total. Among clinical cardiac electrophysiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$174,345in general payments, 2019–2025

Across 213 payments — averaging $818.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ZOLL Respicardia, Inc.$73K
Medtronic$57K
Boston Scientific$36K
Philips North America LLC$8K
Biosense Webster, Inc.$367
Abbott$303
plus $268 from 4 others

$377,807in research payments, 2019–2025

Across 108 payments — averaging $3498.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$191K
ZOLL Respicardia, Inc.$117K
Medtronic$58K
Abbott$12K

What the payments were for

Consulting fees$15,4389%
Speaking & faculty fees$126,05072%
Travel & lodging$22,70013%
Food & beverage$10,0876%
Education$710%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ZOLL Respicardia, Inc.	27	$72,527
Medtronic(2 entities)	84	$56,661
Boston Scientific	75	$36,279
Philips North America LLC	16	$7,940
Biosense Webster, Inc.	5	$367
Abbott	2	$303
Altathera Pharmaceuticals LLC	1	$127
Vektor Medical Inc.	1	$114
Abiomed	1	$15
Merck	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$174,345 in reported general payments places this provider in the 90th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$245,454

Medicare patients

1,235

Services billed

1,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	248	$308,468
XareltoRivaroxaban	68	$68,573
EntrestoSacubitril/Valsartan	14	$21,256
Dofetilide	77	$11,600
Quinidine Gluconate	14	$10,060
Propafenone Hcl ErPropafenone Hcl	28	$10,011
Mexiletine Hcl	47	$8,670
Amiodarone Hcl	143	$3,898
Dabigatran EtexilateDabigatran Etexilate Mesylate	11	$2,956
SotalolSotalol Hcl	96	$2,498
Metoprolol Succinate	146	$2,455
Flecainide Acetate	27	$1,082
Diltiazem 24hr Er (Cd)Diltiazem Hcl	41	$1,062
Losartan Potassium	45	$538
Potassium Chloride	20	$390

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Columbus

Anish AminColumbus$1.1M
John HummelColumbus$275K
Auroa BadinColumbus$188K
David NemerColumbus$97K
Eugene FuColumbus$96K
Ankur ShahColumbus$75K
Sampath GundaColumbus$73K
Sreedhar BillakantyColumbus$64K
Salvatore SavonaColumbus$49K
Natee SirinvaravongColumbus$44K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →